B. Wood

J. Radich, A. Logan, B. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?

E. Estey, J. Radich, B. Wood, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre- and Post-Transplant Quantification of Measurable (“Minimal”) Residual Disease via Multiparameter Flow Cytometry in Adult Acute Myeloid Leukemia

E. Estey, J. Radich, B. Wood, 2016, Leukemia.

Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome

J. Abkowitz, B. Wood, A. Shimamura, 2016, Science Translational Medicine.

Cyclin-A1 represents a new immunogenic targetable antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer-testis antigen.

Thomas M. Schmitt, I. Weissman, K. Loeb, 2012, Blood.

Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia

E. Estey, J. Abkowitz, B. Wood, 2014, Leukemia.

Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.

H. Deeg, Emily A. Stevens, B. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome.

B. Wood, B. Sandmaier, T. Gooley, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

Ashley D. Hill, M. Loh, J. Downing, 2019, Nature Genetics.

Anti-CD19 Chimeric Antigen Receptor-Modified T Cell Therapy for B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Fludarabine and Cyclophosphamide Lymphodepletion Improves In Vivo Expansion and Persistence of CAR-T Cells and Clinical Outcomes

S. Heimfeld, B. Wood, D. Maloney, 2015 .

Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

B. Wood, G. Marcucci, Xiuli Wang, 2017 .

Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL

S. Steinberg, S. Grupp, B. Wood, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In Situ Distribution of Hepatitis C Virus Replicative-Intermediate RNA in Hepatic Tissue and Its Correlation with Liver Disease

B. Wood, D. Gretch, R. Carithers, 2000, Journal of Virology.

Four-color flow cytometry identifies virtually all cytogenetically abnormal bone marrow samples in the workup of non-CML myeloproliferative disorders.

B. Wood, S. Kussick, B. Wood, 2003, American journal of clinical pathology.

A phase I/II study of oral clofarabine plus low‐dose cytarabine in previously treated acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients at least 60 years of age

E. Estey, B. Wood, J. Pagel, 2015, British journal of haematology.

CD44H and CD44V6 Expression in Different Subtypes of Hodgkin Lymphoma

B. Wood, Faten Anwar, B. Wood, 2000, Modern Pathology.

Diagnosis and classification of lymphoma based on cytospin preparations: A comparison of hematopathologists and cytopathologists

M. Sack, S. Perkins, B. Wood, 2000, Diagnostic cytopathology.

Therapeutics , Targets , and Chemical Biology A Preclinical Model of CD 38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies

B. Wood, J. Pagel, T. Gooley, 2014 .

Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

M. Loh, B. Wood, S. Hunger, 2010 .

Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party

J. Philippé, B. Wood, F. Lacombe, 2021, HemaSphere.

Monitoring minimal residual disease in acute leukemia: Technical challenges and interpretive complexities.

B. Wood, Xueyan Chen, B. Wood, 2017, Blood reviews.

A phase I / II trial of iodine-131 – tositumomab ( anti-CD 20 ) , etoposide , cyclophosphamide , and autologous stem cell transplantation for relapsed B-cell lymphomas

S. A. Bush, I. Bernstein, J. Eary, 2000 .

Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte–colony‐stimulating factor by single‐dose administration of AMD3100, a CXCR4 antagonist

B. Wood, H. Broxmeyer, K. Badel, 2005, Transfusion.

Detection of non-CLL-like monoclonal B cell lymphocytosis increases dramatically in the very elderly, while detection of CLL-like populations varies by race: findings in a multiethnic population-based cohort of elderly women

A. Reiner, B. Wood, A. D. De Roos, 2016, Annals of Hematology.

Interactions between mouse IgG2 antibodies are common and mediated by plasma C1q

B. Wood, Greg R Levin, Greg R. Levin, 2006, Cytometry. Part B, Clinical cytometry.

Mobilization Of Blasts and Leukemia Stem Cells by Anti-CXCR4 Antibody BMS-936564 (MDX 1338) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

E. Estey, B. Wood, F. Appelbaum, 2013 .

Distinct hematopoietic stem/progenitor cell populations are responsible for repopulating NOD/SCID mice compared with nonhuman primates.

B. Wood, P. Horn, H. Kiem, 2003, Blood.

Refrigerated storage improves the stability of the complete blood cell count and automated differential.

B. Wood, D. Sabath, S. Miller, 1999, American journal of clinical pathology.

Flow Cytometric Detection of the Classical Hodgkin Lymphoma: Clinical and Research Applications

B. Wood, J. Fromm, M. Roshal, 2010, Advances in hematology.

The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome.

B. Wood, D. Dale, A. Bolyard, 2011, Blood.

chemical inducers of dimerization Expansion of genetically modified primary human hemopoietic cells using

B. Wood, C. A. Blau, T. Papayannopoulou, 2013 .

The genomic landscape of pediatric acute lymphoblastic leukemia

Diane A. Flasch, Samuel W. Brady, Michael C. Rusch, 2022, Nature Genetics.

Blood and gastric FOXP3+ T cells are not decreased in human gastric graft-versus-host disease.

S. Ziegler, B. Wood, D. Hockenbery, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of T-cell receptor gene rearrangement for predicting clinical outcome in patients with cutaneous T-cell lymphoma: a comparison of Southern blot and polymerase chain reaction methods.

N. Polissar, J. Olerud, B. Wood, 2005, Archives of dermatology.

The Detection and Significance of Minimal Residual Disease

J. Radich, B. Wood, B. Wood, 2012 .

Multicolor immunophenotyping: human immune system hematopoiesis.

B. Wood, B. Wood, 2004, Methods in cell biology.

2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document.

K. Döhner, M. Heuser, F. Thol, 2021, Blood.

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

M. Heuser, F. Thol, T. Haferlach, 2021 .

High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector.

B. Wood, R. Humphries, R. Humphries, 2008, The Journal of clinical investigation.

Results of a phase I‐II study of fenretinide and rituximab for patients with indolent B‐cell lymphoma and mantle cell lymphoma

B. Wood, J. Pagel, T. Gooley, 2017, British journal of haematology.

JAK3 Mutations and Mitochondrial Apoptosis Resistance in T-Cell Acute Lymphoblastic Leukemia

M. Loh, A. Letai, L. Silverman, 2022, Leukemia.

AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report

Emily A. Stevens, J. Radich, B. Wood, 2020, Biomarker Research.

Impact of Pre-Transplant Measurable Residual Disease on Outcome of Allogeneic Hematopoietic Cell Transplantation in Adult Monosomal Karyotype AML

B. Wood, R. Storb, B. Sandmaier, 2020, Leukemia.

Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation

B. Wood, B. Sandmaier, B. Storer, 2012, Cancer.

Lymphomatoid papulosis with CD1a+ dendritic cell hyperplasia, mimicking Langerhans cell histiocytosis

Z. Argényi, J. Olerud, B. Wood, 2007, Journal of cutaneous pathology.

Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting.

B. Wood, J. Fromm, Anju Thomas, 2017, The American journal of pathology.

Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry.

B. Wood, A. Chang, S. Kussick, 2003, American journal of clinical pathology.

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

B. Wood, C. Hourigan, M. Linden, 2017, Haematologica.

Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high‐risk MDS

E. Estey, B. Wood, J. Singer, 2016, British journal of haematology.

Effect of Measurable (“Minimal”) Residual Disease (MRD) Information on Prediction of Relapse and Survival in Adult Acute Myeloid Leukemia

E. Estey, B. Wood, D. Stirewalt, 2016, Leukemia.

Reply to the letter from Drs Matutes and Catovsky

B. Wood, D. Sabath, S. Kussick, 2003, Leukemia.

Masked Hypodiploidy: Hypodiploid Acute Lymphoblastic Leukemia (ALL) in Children Mimicking Hyperdiploid ALL: A Report From the Children's Oncology Group (COG) AALL03B1 Study.

M. Loh, J. Gastier-Foster, N. Heerema, 2009 .

Early T‐Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia

B. Wood, David Wu, S. Bunting, 2016, Pediatric blood & cancer.

Amplification of AML1 Does Not Impact Early Outcome of Children with Acute Lymphoblastic Leukemia (ALL) Treated with Risk-Directed Chemotherapy: A Report From the Children's Oncology Group (COG).

M. Loh, N. Heerema, B. Wood, 2009 .

Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia

B. Wood, B. Sandmaier, F. Appelbaum, 2022, Haematologica.

SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome–Negative B-Cell Acute Lymphoblastic Leukemia

B. Wood, C. Willman, W. Stock, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis

B. Wood, J. Fromm, S. Cherian, 2016, Cytometry. Part B, Clinical cytometry.

Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T‐acute lymphoblastic leukemia and T‐lymphoblastic lymphoma (study T2008‐002 NECTAR)

L. Silverman, B. Wood, A. Attarbaschi, 2022, Pediatric blood & cancer.

Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.

E. Estey, M. Bar, B. Wood, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4.

M. Loh, J. Gastier-Foster, N. Heerema, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.

M. Loh, M. Shago, S. Raimondi, 2019, Cancer genetics.

Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T‐cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434

M. Loh, J. Gastier-Foster, N. Heerema, 2015, Pediatric blood & cancer.

Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist.

B. Wood, H. Broxmeyer, G. Bridger, 2004, Supportive cancer therapy.

The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia

B. Wood, C. Correnti, H. Kiem, 2020, Leukemia.

Aberrant STAT 5 and PI 3 K / mTOR pathway signaling occurs in human CRLF 2-rearranged B-precursor acute lymphoblastic leukemia

M. Loh, J. Gastier-Foster, C. Mullighan, 2012 .

VpreB surrogate light chain expression in B-lineage ALL: a report from the Children’s Oncology Group

Chunxu Qu, N. Heerema, C. Mullighan, 2021, Blood advances.

Acute Myeloid Leukemia Measurable Residual Disease Detection by Flow Cytometry in Peripheral Blood Versus Bone Marrow.

E. Estey, B. Wood, M. Othus, 2020, Blood.

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

H. Deeg, B. Wood, R. Storb, 2020, Cancers.

Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission

B. Wood, R. Storb, B. Sandmaier, 2019, Bone Marrow Transplantation.

Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

B. Wood, H. Kantarjian, G. Martinelli, 2021, Cancers.

Treosulfan, Fludarabine and 2 Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with MDS and AML

E. Estey, M. Bar, B. Wood, 2014 .

Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization.

B. Wood, C. A. Blau, T. Papayannopoulou, 2000, Blood.

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia.

M. Loh, D. Teachey, S. Grupp, 2018, Blood.

Lintuzumab and Low-Dose Cytarabine Compared to Placebo and Low-Dose Cytarabine in Patients with Untreated Acute Myeloid Leukemia (AML) 60 Years and Older: Results of a Randomized, Double-Blinded Phase 2b Study,

B. Wood, J. Lancet, M. Sekeres, 2011 .

Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission

E. Estey, M. Bar, B. Wood, 2015, Leukemia & lymphoma.

A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.

S. A. Bush, I. Bernstein, J. Eary, 2000, Blood.

Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease

K. Loeb, S. Heimfeld, B. Wood, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor derived T-cell large granular lymphocyte leukemia after cord blood transplant for pediatric T-cell lymphoblastic leukemia

B. Wood, David Wu, J. Fromm, 2018, Bone Marrow Transplantation.

Clinicopathologic features of primary colonic enteropathy-associated T cell lymphoma type II in an elderly Asian male with diarrhea

B. Wood, Jey-Hsin Chen, S. Kussick, 2015, Journal of Hematopathology.

PCR methods for determining B cell clonality.

B. Wood, D. Sabath, S. Kussick, 2000, The Journal of molecular diagnostics : JMD.

Immune defects in a mouse model of Fanconi anaemia

B. Wood, E. Goren, P. Becker, 2012, British journal of haematology.

Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing

A. E. Yeo, B. Wood, D. Gretch, 2006, Hepatology.

Clinical Experience With Modified, Single-Tube T-Cell Receptor Vβ Flow Cytometry Analysis for T-Cell Clonality.

B. Wood, David Wu, M. Othus, 2016, American journal of clinical pathology.

T-cell clonality determination using polymerase chain reaction (PCR) amplification of the T-cell receptor gamma-chain gene and capillary electrophoresis of fluorescently labeled PCR products.

B. Wood, J. Sprouse, D. Sabath, 2000, American journal of clinical pathology.

CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.

Daniel Li, Jianhong Cao, Xueyan Chen, 2016, The Journal of clinical investigation.

Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.

E. Estey, J. Abkowitz, B. Wood, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

Torsten Haferlach, Claude Preudhomme, Wolfgang Kern, 2018, Blood.

Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis

D. Berry, J. Radich, B. Wood, 2017, JAMA oncology.

Minimal residual disease testing in acute leukemia

B. Wood, L. Soma, B. Wood, 2013 .

Flow cytometric monitoring of residual disease in acute leukemia.

B. Wood, B. Wood, 2013, Methods in molecular biology.

Next-Generation Sequencing for Measurable Residual Disease Assessment in Acute Leukemia

B. Wood, G. Raca, D. Bhojwani, 2021, Advances in Molecular Pathology.

The minimal that kills: Why defining and targeting measurable residual disease is the "Sine Qua Non" for further progress in management of acute myeloid leukemia.

J. Radich, B. Wood, S. Halene, 2019, Blood reviews.

Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia

E. Estey, B. Wood, F. Appelbaum, 2019, Bone Marrow Transplantation.

Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1

B. Wood, David Wu, S. Salipante, 2018, Cytometry. Part B, Clinical cytometry.

Comparison of Minimal Residual Disease as Outcome Predictor for AML Patients in First Complete Remission Undergoing Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

B. Wood, M. Sorror, R. Storb, 2013, Leukemia.

Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals

B. Wood, C. Marra, L. Tantalo, 2004, Neurology.

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

W. Klapper, H. Dombret, R. Foà, 2017, The New England journal of medicine.

Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.

Jinjuan Wang, Brent L Wood, Xiaojun Qian, 2008, Blood.

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

S. Heimfeld, B. Wood, D. Maloney, 2016, Science Translational Medicine.

Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

B. Wood, C. Stehman-Breen, V. Broudy, 1998, Transplantation.

Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.

E. Estey, B. Wood, M. Sorror, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.

Brent L Wood, Sampa Pal, B. Wood, 2006, Gastroenterology.

Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells.

O. Elemento, S. Rafii, Michael G. Poulos, 2015, The Journal of clinical investigation.

Identification of a Human Heme Exporter that Is Essential for Erythropoiesis

J. Abkowitz, B. Wood, J. Quigley, 2004, Cell.

2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications

A Orfao, B L Wood, R C Braylan, 2007, Cytometry. Part B, Clinical cytometry.

PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia

M. Loh, A. Letai, D. Neuberg, 2018, The Journal of experimental medicine.

Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

E. Kroh, M. Tewari, B. Wood, 2011, Cancer Prevention Research.

Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.

M. Loh, J. Downing, D. Gerhard, 2013, Blood.

report from The Children's Oncology Group TARGET Project Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a

Michael N. Edmonson, M. Loh, J. Downing, 2012 .

Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors

B. Wood, G. Vassilopoulos, D. Russell, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.

Renato Martins, Colin C Pritchard, Stephen J Salipante, 2014, The Journal of molecular diagnostics : JMD.

Langerhans Cell Homeostasis and Turnover After Nonmyeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation

M. Merad, B. Wood, R. Storb, 2014, Transplantation.

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma

Steve Y. Cho, M. Loh, Zhiguo Chen, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622.

M. Loh, J. Gastier-Foster, N. Heerema, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.

H. Deeg, B. Wood, M. Sorror, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD44 promotes chemoresistance in T-ALL by increased drug efflux.

A. Weng, B. Wood, V. Giambra, 2016, Experimental hematology.

A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication

B. Wood, D. Stirewalt, E. Pogosova-Agadjanyan, 2004, Leukemia.

Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331.

M. Loh, J. Gastier-Foster, N. Heerema, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199.

M. Loh, A. Letai, S. Sallan, 2014, Cancer discovery.

Flow cytometric features of incidental indolent T lymphoblastic proliferations

B. Wood, David Wu, K. Edlefsen, 2020, Cytometry. Part B, Clinical cytometry.

The Flow Cytometric Evaluation of Hematopoietic Neoplasia

B. Wood, M. Borowitz, B. Wood, 2011 .

Immaturity associated antigens are lost during induction for T cell lymphoblastic leukemia: Implications for minimal residual disease detection

B. Wood, S. Winter, K. Dunsmore, 2010, Cytometry. Part B, Clinical cytometry.

Immunophenotyping of Leukemia and Lymphoma by Flow Cytometry

B. Wood, B. Wood, 2006 .

Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.

Julie M Gastier-Foster, Brent L Wood, M. Loh, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part V – assay performance criteria

Ming Yan, Virginia Litwin, Ming Yan, 2013, Cytometry. Part B, Clinical cytometry.

Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.

M. Loh, J. Gastier-Foster, N. Heerema, 2017, Blood.

The genetic basis and cell of origin of mixed phenotype acute leukaemia

Richard A. Moore, M. Loh, J. Downing, 2018, Nature.

Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932

M. Loh, M. Relling, N. Heerema, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232.

M. Loh, J. Gastier-Foster, N. Heerema, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children’s Oncology Group (COG)

M. Loh, J. Gastier-Foster, N. Heerema, 2017, Leukemia.

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

M. Loh, D. Teachey, J. Hall, 2015, Blood.

T-Lymphoblastic Leukemia (T-ALL) Shows Excellent Outcome, Lack of Significance of the Early Thymic Precursor (ETP) Immunophenotype, and Validation of the Prognostic Value of End-Induction Minimal Residual Disease (MRD) in Children’s Oncology Group (COG) Study AALL0434

M. Loh, B. Wood, S. Hunger, 2014 .

Patients with Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia (ALL) Have High Levels of Minimal Residual Disease (MRD) at the End of induction—A Children's Oncology Group (COG) Study.

M. Loh, B. Wood, S. Hunger, 2009 .

Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia

J. Taunton, D. Teachey, T. Ryan, 2022, British journal of haematology.

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia.

M. Loh, J. Gastier-Foster, Zhiguo Chen, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Applications of Flow Cytometric Immunophenotyping in the Diagnosis and Posttreatment Monitoring of B and T Lymphoblastic Leukemia/Lymphoma

B. Wood, Joseph A. DiGiuseppe, B. Wood, 2019, Cytometry. Part B, Clinical cytometry.

MLL Rearrangements Impact Outcome in HOXA-deregulated T-lineage Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

Michael C. Rusch, M. Loh, N. Heerema, 2016, Leukemia.

Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemia

M. Loh, D. Neuberg, S. Sallan, 2018, Leukemia.

Deep NPM1 Sequencing Following Allogeneic Hematopoietic Cell Transplantation Improves Risk Assessment in Adults with NPM1-Mutated AML.

E. Estey, B. Wood, David Wu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Decreased IRF8 expression found in aging hematopoietic progenitor/stem cells

J. Radich, S. Heimfeld, N. Sharpless, 2009, Leukemia.

Decreased IRF 8 Expression in Aging Hematopoietic Progenitor / Stem Cells

J. Radich, S. Heimfeld, N. Sharpless, 2008 .

Flow Cytometric Evaluation of Skin Biopsies for Mycosis Fungoides

Z. Argényi, J. Olerud, B. Wood, 2011, The American Journal of dermatopathology.

Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children’s Oncology Group Study AALL0232

M. Loh, J. Gastier-Foster, Zhiguo Chen, 2021, Leukemia.

Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group.

M. Loh, J. Gastier-Foster, N. Heerema, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.

M. Loh, J. Gastier-Foster, N. Heerema, 2018, Blood.

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

Guido Marcucci, Marco Marra, Zhaohui Gu, 2016, Nature Communications.

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

M. Loh, M. Relling, Cheng Cheng, 2013, Nature Genetics.

Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG

M. Loh, N. Heerema, B. Wood, 2018, Haematologica.

TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children.

R. Fulton, E. Mardis, M. Loh, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Glucocorticoids paradoxically facilitate steroid resistance in T-cell acute lymphoblastic leukemias and thymocytes.

A. Olshen, D. Teachey, B. Wood, 2020, The Journal of clinical investigation.

Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

M. Loh, Zhiguo Chen, D. Teachey, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia

B. Wood, M. Schrappe, C. Bartram, 2018, JNCI cancer spectrum.

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.

M. Loh, B. Wood, H. Robins, 2018, Blood.

How do we measure MRD in ALL and how should measurements affect decisions. Re: Treatment and prognosis?

B. Wood, Xueyan Chen, B. Wood, 2017, Best practice & research. Clinical haematology.

Capizzi-Style Methotrexate with Pegasparagase (C-MTX) Is Superior to High-Dose Methotrexate (HDMTX) in T-Lineage Acute Lymphoblastic Leukemia (T-ALL): Results from Children's Oncology Group (COG) AALL0434

M. Loh, N. Heerema, B. Wood, 2015 .

Assessment of end induction minimal residual disease (MRD) in childhood B precursor acute lymphoblastic leukemia (ALL) to eliminate the need for day 14 marrow examination: A Children’s Oncology Group study.

M. Loh, J. Gastier-Foster, N. Heerema, 2013 .

Cytogenetic and early-response characteristics of adolescents and young adults with acute lymphoblastic leukemia (ALL): A Children's Oncology Group (COG) study.

M. Loh, J. Gastier-Foster, N. Heerema, 2010 .

Inherited genetic susceptibility of acute lymphoblastic leukemia in Down syndrome.

Noah A. Kallsen, Shanna A. Peyton, Austin L. Brown, 2019, Blood.

Immunophenotyping of classical Hodgkin’s lymphoma by flow cytometry

B. Wood, J. Fromm, 2013, Annals of Hematology.

Computer-aided detection of rare tumor populations in flow cytometry: an example with classic Hodgkin lymphoma.

David Wu, David P Ng, Brent L Wood, 2015, American journal of clinical pathology.

Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity.

Anju Thomas, Brent L Wood, Jonathan R Fromm, 2009, American journal of clinical pathology.

Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics.

M. Loh, M. Relling, C. Pui, 2019, Blood.

A novel flow cytometric assay for detection of residual disease in patients with B‐lymphoblastic leukemia/lymphoma post anti‐CD19 therapy

B. Wood, J. Fromm, S. Cherian, 2018, Cytometry. Part B, Clinical cytometry.

A Distributed Network for Intensive Longitudinal Monitoring in Metastatic Triple-Negative Breast Cancer.

Chris P. Miller, D. Haussler, Su-In Lee, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project

Kiran C. Bobba, Kimberly J. Johnson, R. Wilson, 2011 .

CD20-specific T cells mantle cell lymphoma using genetically modified autologous Adoptive immunotherapy for indolent non-Hodgkin lymphoma and

B. Wood, S. Riddell, P. Greenberg, 2011 .

Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3)

F. Behm, N. Heerema, C. Felix, 2015, Pediatric blood & cancer.

SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia

J. Radich, B. Wood, F. Appelbaum, 2014, British journal of haematology.

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Techniques and Application

B. Wood, Xueyan Chen, B. Wood, 2022, Clinical Management of Acute Lymphoblastic Leukemia.

Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.

B. Wood, B. Wood, 2007, Clinics in laboratory medicine.

Measurable Residual Disease Detection in B‐Acute Lymphoblastic Leukemia: The Children's Oncology Group (COG) Method

B. Wood, M. Borowitz, M. Keeney, 2022, Current protocols.

Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children’s Oncology Group phase III study AALL0433

Xiaomin Lu, B. Wood, S. Hunger, 2020, Haematologica.

A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters

Gary Kelloff, Gerard Lozanski, Brent L Wood, 2018, Cytometry. Part B, Clinical cytometry.

Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.

M. Loh, J. Gastier-Foster, N. Heerema, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children’s Oncology Group Study AALL08P1

M. Loh, N. Heerema, B. Wood, 2016, Journal of pediatric hematology/oncology.

Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry

Brent L Wood, B. Wood, B. Wood, 2016, Cytometry. Part B, Clinical cytometry.

Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH

David Wu, Christopher Carlson, Brent L Wood, 2014, Clinical Cancer Research.

Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.

M. Loh, J. Gastier-Foster, N. Heerema, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data

Tomáš Sieger, Karel Fišer, Angela Schumich, 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high‐risk stratum of patients with newly diagnosed high‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131

M. Loh, N. Heerema, B. Wood, 2018, Cancer.

Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331

M. Loh, J. Gastier-Foster, N. Heerema, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cord-Blood Transplantation in Patients with Minimal Residual Disease.

B. Wood, M. Sorror, B. Sandmaier, 2016, The New England journal of medicine.

Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia.

Y. Li, B. Wood, T. Norwood, 2005, American journal of clinical pathology.

A BCR-ABL1-Like Gene Expression Profile Confers a Poor Prognosis In Patients with High-Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report From Children's Oncology Group (COG) AALL0232

M. Loh, J. Gastier-Foster, N. Heerema, 2011 .

Isolated late testicular relapse of B‐cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response‐based testicular radiation: A Children's Oncology Group study

M. Loh, J. Gastier-Foster, B. Wood, 2018, Pediatric blood & cancer.

Immunophenotypic Features of Myeloid Neoplasms Associated with Chromosome 7 Abnormalities

B. Wood, S. Cherian, Xueyan Chen, 2019, Cytometry. Part B, Clinical cytometry.

Review Article Flow Cytometric Detection of the Classical Hodgkin Lymphoma: Clinical and Research Applications 1. Clinical Diagnosis of Classical Hodgkin Lymphoma by Flow Cytometry

B. Wood, J. Fromm, M. Roshal, 2022 .

The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.

Brent L Wood, Katherine A Guthrie, Janis L Abkowitz, 2009, Blood.

9-color and 10-color flow cytometry in the clinical laboratory.

B. Wood, Brent Wood, B. Wood, 2006, Archives of pathology & laboratory medicine.

No evidence of clonal dominance after transplant of HOXB4-expanded cord blood cells in a nonhuman primate model.

B. Wood, R. Humphries, H. Kiem, 2014, Experimental hematology.

Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High Risk B-Lymphoblastic Leukemia: Results of Children's Oncology Group Study AALL1131

M. Loh, N. Heerema, B. Wood, 2018, Blood.

Intensification of Oral Methotrexate Is Not Superior to Standard Methotrexate Dosing during Maintenance in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932

M. Loh, Xiaomin Lu, N. Heerema, 2017 .

Methods of Detection of Measurable Residual Disease in AML

B. Wood, Yi Zhou, B. Wood, 2017, Current Hematologic Malignancy Reports.

Detection of minimal residual disease in NPM1-mutated acute myeloid leukemia by next-generation sequencing

J. Shendure, B. Wood, David Wu, 2014, Modern Pathology.

Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.

A. Gown, B. Wood, G. Starkebaum, 2001, The Journal of rheumatology.

Clinical Flow Cytometry for Hematopoietic Neoplasms

B. Wood, David Wu, J. Fromm, 2016 .

Genome-wide association study of susceptibility loci for T-cell acute lymphoblastic leukemia in children.

M. Loh, M. Relling, C. Pui, 2019, Journal of the National Cancer Institute.

Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations.

R. Braziel, B. Wood, S. Kussick, 2004, American journal of clinical pathology.

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.

S. A. Bush, I. Bernstein, J. Eary, 2002, Blood.

The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

Thomas M. Schmitt, B. Wood, D. Maloney, 2010, Blood.

Ten‐Color Immunophenotyping of Hematopoietic Cells

B. Wood, 2005, Current protocols in cytometry.

2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia

Bruce Greig, Brent L Wood, Teri Oldaker, 2007, Cytometry. Part B, Clinical cytometry.

Anatomical Compartments Modify the Response of Human Hematopoietic Cells to a Mitogenic Signal

B. Wood, T. Papayannopoulou, Wenjin Guo, 2006, Stem cells.

A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.

B. Wood, J. Pagel, T. Gooley, 2014, Cancer research.

The genetic basis and cell of origin of mixed phenotype acute leukaemia

Steven J. M. Jones, Richard A. Moore, M. Loh, 2018, Nature.

Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease

B. Wood, B. Sandmaier, F. Appelbaum, 2019, Leukemia.

Flow cytometric evaluation of CD38 expression assists in distinguishing follicular hyperplasia from follicular lymphoma

B. Wood, K. Mantei, 2009, Cytometry. Part B, Clinical cytometry.

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

S. Steinberg, S. Grupp, B. Wood, 2022, Blood advances.

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials

E. Estey, B. Wood, D. Stirewalt, 2018, Leukemia.

Abstract PR14: CD123CAR displays clinical activity in relapsed/refractory (r/r) acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN): Safety and efficacy results from a phase 1 study

B. Wood, G. Marcucci, S. Forman, 2020 .

Flow Cytometry for Non-Hodgkin and Hodgkin Lymphomas.

B. Wood, David Wu, J. Fromm, 2019, Methods in molecular biology.

in adult B cell ALL patients

S. Heimfeld, B. Wood, D. Maloney, 2016 .

A Phase 1b Study of Vadastuximab Talirine As Maintenance and in Combination with Standard Consolidation for Patients with Acute Myeloid Leukemia (AML)

Scott E. Smith, B. Wood, M. Maris, 2016 .

A Phase 1b Study of Vadastuximab Talirine in Combination with 7+3 Induction Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Scott E. Smith, B. Wood, M. Maris, 2016 .

Fully Human Bcma Targeted Chimeric Antigen Receptor T Cells Administered in a Defined Composition Demonstrate Potency at Low Doses in Advanced Stage High Risk Multiple Myeloma

B. Wood, D. Maloney, F. Appelbaum, 2018, Blood.

Southwest Oncology Group Study S0910: A Phase 2 Trial of Clofarabine/ Cytarabine/ Epratuzumab for Relapsed/ Refractory Acute Lymphocytic Leukemia.

J. Radich, B. Wood, F. Appelbaum, 2009 .

Cranial Radiation Can be Eliminated in Most Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) and Bortezomib Potentially Improves Survival in Children with T-Cell Lymphoblastic Lymphoma (T-LL): Results of Children's Oncology Group (COG) Trial AALL1231

Steve Y. Cho, M. Loh, Zhiguo Chen, 2020 .

COG AALL0434: A randomized trial testing nelarabine in newly diagnosed t-cell malignancy.

M. Loh, J. Gastier-Foster, N. Heerema, 2018 .

Rate of durable complete response in ALL, NHL, and CLL after immunotherapy with optimized lymphodepletion and defined composition CD19 CAR-T cells.

K. Loeb, S. Heimfeld, B. Wood, 2016 .

2006 Bethesda International Consensus Conference on Flow Cytometric Immunophenotyping of Hematolymphoid Neoplasia

B. Wood, R. Braylan, M. Stetler-Stevenson, 2007, Cytometry. Part B, Clinical cytometry.

2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Recommendations for training and education to perform clinical flow cytometry

B. Wood, M. Warzynski, B. Greig, 2007, Cytometry. Part B, Clinical cytometry.

Umbrella Trial in Myeloid Malignancies: The Myelomatch National Clinical Trials Network Precision Medicine Initiative

J. Radich, B. Freidlin, B. Wood, 2022, Blood.

Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children’s Oncology Group

M. Loh, J. Gastier-Foster, N. Heerema, 2019, Haematologica.

Flow cytometry in the diagnosis and monitoring of acute leukemia in children

B. Wood, B. Wood, 2015, Journal of Hematopathology.

Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD

B. Wood, B. Sandmaier, P. Becker, 2018, American journal of hematology.

Evaluation of allogeneic transplantation in first or later minimal residual disease – negative remission following adult-inspired therapy for acute lymphoblastic leukemia

M. Bar, B. Wood, M. Sorror, 2016, Leukemia & lymphoma.

Nelarabine in Combination with Etoposide and Cyclophosphamide Is Active in First Relapse of Childhood T-Acute Lymphocytic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)

L. Silverman, B. Wood, C. Zwaan, 2014 .

Mixed‐phenotype acute leukemia: A cohort and consensus research strategy from the Children’s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force

M. Loh, N. Heerema, C. Mullighan, 2020, Cancer.

The value of secondary pathology review.

Tinisha L. Mayo, B. Wood, R. Cheney, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of an 8‐color flow cytometric reference method for white blood cell differential enumeration

B. Wood, S. Cherian, D. Kuhn, 2010, Cytometry. Part B, Clinical cytometry.

Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow.

E. Estey, B. Wood, M. Othus, 2021, Blood.

Acute Myeloid Leukemia Minimal Residual Disease Detection: The Difference from Normal Approach

B. Wood, B. Wood, 2020, Current protocols in cytometry.

Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part I – rationale and aims

Teri Oldaker, B. Wood, B. Davis, 2013, Cytometry. Part B, Clinical cytometry.

Comparison of myeloid blast counts and variant allele frequencies of gene mutations in myelodysplastic syndrome with excess blasts and secondary acute myeloid leukemia

E. Estey, J. Abkowitz, B. Wood, 2020, Leukemia & lymphoma.

Comparative Analysis of Total Body Irradiation (TBI)-Based and Non-TBI-Based Myeloablative Conditioning for Acute Myeloid Leukemia in Remission with and without Measurable Residual Disease

H. Deeg, B. Wood, B. Sandmaier, 2019, Blood.

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

Ashley D. Hill, M. Loh, J. Downing, 2019, Nature Genetics.

Prominent Clonal B-Cell Populations Identified by Flow Cytometry in Histologically Reactive Lymphoid Proliferations

R. Braziel, B. Wood, S. Kussick, 2004 .

Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre‐transplant minimal residual disease reduction

L. Silverman, B. Wood, J. Whitlock, 2020, Pediatric blood & cancer.

"Double-Hit" mature B-cell lymphomas show a common immunophenotype by flow cytometry that includes decreased CD20 expression.

B. Wood, David Wu, J. Fromm, 2010, American journal of clinical pathology.

Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.

M. Loh, J. Gastier-Foster, Zhiguo Chen, 2023, The Lancet. Haematology.

Flow cytometry for non-Hodgkin and classical Hodgkin lymphoma.

David Wu, Brent L Wood, Jonathan R Fromm, 2013, Methods in molecular biology.

Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Refractory Multiple Myeloma

B. Wood, D. Maloney, C. Turtle, 2019, Blood.

Response to Bcma CAR-T Cells Correlates with Pretreatment Target Antigen Density and Is Improved By Small Molecule Inhibition of Gamma Secretase

B. Wood, D. Maloney, S. Riddell, 2019, Blood.

Apparent CD19 expression by natural killer cells: A potential confounder for minimal residual disease detection by flow cytometry in B lymphoblastic leukemia

B. Wood, David Wu, K. Edlefsen, 2014, Cytometry. Part B, Clinical cytometry.

Gene expression signature associated with in vitro dexamethasone resistance and post-induction minimal residual disease in pediatric T-cell acute lymphoblastic leukemia.

M. Loh, A. Olshen, D. Teachey, 2019, Journal of Clinical Oncology.

Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting.

B. Wood, J. Fromm, S. Kussick, 2006, American journal of clinical pathology.

Dasatinib/Prednisone Induction Followed by Blinatumomab/Dasatinib in Ph+ Acute Lymphoblastic Leukemia.

B. Wood, S. O'brien, M. Othus, 2022, Blood advances.

Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with Newly Diagnosed Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia

B. Wood, W. Stock, R. Stone, 2018, Blood.

Comparative analysis of flow cytometry and morphology for the detection of acute myeloid leukaemia cells in cerebrospinal fluid

E. Estey, J. Abkowitz, K. Loeb, 2016, British journal of haematology.

Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients.

L. Beppu, J. Radich, B. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of Patients with CRLF2-Overexpressing Acute Lymphoblastic Leukemia without Down Syndrome: A Report from the Children's Oncology Group

M. Loh, J. Gastier-Foster, N. Heerema, 2020 .

A Phase 2 Study of Ruxolitinib with Chemotherapy in Children with Philadelphia Chromosome-like Acute Lymphoblastic Leukemia (AALL1521/INCB18424-269): Biologic Characteristics and Minimal Residual Disease Response of Patients with Non-CRLF2-Rearranged JAK Pathway Alterations

M. Loh, B. Wood, S. Hunger, 2022, Blood.

Safety and Efficacy of Fully Human BCMA CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase BCMA Surface Expression in Patients with Relapsed or Refractory Multiple Myeloma

B. Wood, D. Maloney, C. Turtle, 2021, Blood.

HOXB 4-Expanded Cord Blood Cells in a Nonhuman Primate Model

B. Wood, R. Humphries, H. Kiem, 2014 .

Hematopoietic stem cell expansion facilitates multilineage engraftment in a nonhuman primate cord blood transplantation model.

B. Wood, R. Humphries, H. Kiem, 2012, Experimental hematology.

Sex‐based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children’s Oncology Group report

M. Loh, Zhiguo Chen, N. Heerema, 2022, Cancer.